journal article·2025-04Open access

3‐D Sustained‐Release Culture Carrier Alleviates Rat Intervertebral Disc Degeneration by Targeting STING in Transplanted Skeletal Stem Cells

Liwen Luo, Shiyu Zhang, Junfeng Gong, Ji Zhang, Peng Xie, Jun Yin, MengJie Zhang, Cong Zhang, Hong Chen, Yao Liu, Bing Ni, Changqing Li, Zhiqiang Tian

Advanced Science· Volume 12· Issue 15

Abstract

Abstract The hypoxic and high‐pressure microenvironment of the intervertebral discs poses a major challenge to the survival and therapeutic efficiency of exogenous stem cells. Therefore, improving the utilization efficiency and therapeutic effect of exogenous stem cells to delay intervertebral disc degeneration (IVDD) is of great importance. Here, hypoxic induction studies are conducted in vivo and in vitro using rat costal cartilage‐derived skeletal stem cells (SSCs) and find that hypoxia activates the cyclic guanosine monophosphate–adenosine monophosphate synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway and increased reactive oxygen species (ROS) accumulation, triggering ferroptosis in SSCs through hypoxia‐inducible factor‐1 alpha‐dependent mitophagy. Progressive hypoxia preconditioning reduce STING expression and ROS accumulation, inducing SSCs differentiation into nucleus pulposus‐like cells via the Wnt signaling pathway. Considering this, a 3‐D sustained‐release culture carrier is generated by mixing SSCs with methacrylated hyaluronic acid and polydopamine nanoparticles coated with the STING inhibitor C‐176 and evaluated its inhibitory effect on IVDD. This carrier is demonstrated to inhibit the cGAS/STING pathway and prevent ROS accumulation by continuously releasing C‐176‐coated polydopamine nanoparticles, thereby reducing ferroptosis, promoting differentiation, and ultimately attenuating IVDD, suggesting its potential as a novel treatment strategy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · interferon and immune responses · Spine and Intervertebral Disc Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics Xinqiao Hospital Army Medical University (Third Military Medical University) Chongqing P. R. China

State Key Laboratory of Trauma and Chemical Poisoning Army Medical University (Third Military Medical University) Chongqing P. R. China

Department of General Surgery The Armed Police Corps Hospital of Anhui Hefei P. R. China

Institute of Immunology PLA Army Medical University (Third Military Medical University) Chongqing P. R. China

Department of Military Biosafety College of Basic Medicine Army Medical University Chongqing P. R. China

Department of Pathophysiology College of High Altitude Military Medicine Army Military Medical University Chongqing P. R. China

Department of Laboratory Animal Science College of Basic Medicine Army Medical University Chongqing P. R. China

Department of Orthopedics 903 Hospital of Joint Logistic Support Force of The People's Liberation Army Hangzhou P. R. China

Department of Pharmacy Daping Hospital Army Medical University (Third Military Medical University) Chongqing P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Chongqing Municipality

References (73)

Show source-provided references
1. 10.1016/S0140-6736(18)30323-410.1016/S0140-6736(18)30323-4 ↗
2. 10.1016/j.redox.2023.10270710.1016/j.redox.2023.102707 ↗
3. Chao Y. · Bioact. Mater. · 2021 · 6 · 3568
4. Sheng C. · Stem Cells Int. · 2018 · 2017
5. 10.1016/j.ccr.2007.02.02710.1016/j.ccr.2007.02.027 ↗
6. 10.1158/0008-5472.CAN-08-094310.1158/0008-5472.CAN-08-0943 ↗
7. 10.1042/BSR2017018110.1042/BSR20170181 ↗
8. 10.1016/j.cell.2018.07.02910.1016/j.cell.2018.07.029 ↗
9. 10.1038/s41591-020-1013-210.1038/s41591-020-1013-2 ↗
10. 10.1038/s41586-023-06519-110.1038/s41586-023-06519-1 ↗
11. 10.1016/j.cell.2014.12.00210.1016/j.cell.2014.12.002 ↗
12. 10.1038/nrrheum.2015.1310.1038/nrrheum.2015.13 ↗
13. 10.1089/ten.tea.2011.022910.1089/ten.tea.2011.0229 ↗
14. 10.3389/fbioe.2023.108903110.3389/fbioe.2023.1089031 ↗
15. 10.1080/15548627.2022.216224510.1080/15548627.2022.2162245 ↗
16. 10.1002/jbmr.470710.1002/jbmr.4707 ↗
17. 10.1007/s10753-022-01732-y10.1007/s10753-022-01732-y ↗
18. 10.1016/j.redox.2017.02.01410.1016/j.redox.2017.02.014 ↗
19. 10.1016/j.aquatox.2019.04.00110.1016/j.aquatox.2019.04.001 ↗
20. 10.1016/j.ceca.2024.10296610.1016/j.ceca.2024.102966 ↗
21. 10.1186/s10020-023-00730-610.1186/s10020-023-00730-6 ↗
22. 10.1038/mt.2012.21310.1038/mt.2012.213 ↗
23. 10.1016/j.bioactmat.2022.10.01910.1016/j.bioactmat.2022.10.019 ↗
24. Wei Z. Z. · Chin. Med. J. · 2017 · 130 · 2361
25. 10.1038/s41586-023-05770-w10.1038/s41586-023-05770-w ↗
26. 10.1016/j.molcel.2020.12.02410.1016/j.molcel.2020.12.024 ↗
27. 10.1038/s41467-020-20839-010.1038/s41467-020-20839-0 ↗
28. 10.1172/JCI16514010.1172/JCI165140 ↗
29. 10.1038/s12276-022-00729-910.1038/s12276-022-00729-9 ↗
30. 10.1016/j.redox.2023.10269110.1016/j.redox.2023.102691 ↗
31. 10.1016/j.joca.2021.04.01710.1016/j.joca.2021.04.017 ↗
32. 10.1038/s41420-023-01607-710.1038/s41420-023-01607-7 ↗
33. 10.1016/j.jot.2024.03.00510.1016/j.jot.2024.03.005 ↗
34. 10.1016/j.ijbiomac.2024.13133710.1016/j.ijbiomac.2024.131337 ↗
35. 10.1002/adhm.20240110310.1002/adhm.202401103 ↗
36. 10.1021/acsnano.4c0932610.1021/acsnano.4c09326 ↗
37. 10.1016/j.actbio.2022.05.04710.1016/j.actbio.2022.05.047 ↗
38. 10.1038/s41419-022-05121-z10.1038/s41419-022-05121-z ↗
39. 10.1007/s10571-023-01388-810.1007/s10571-023-01388-8 ↗
40. 10.1007/s12192-023-01324-110.1007/s12192-023-01324-1 ↗
41. 10.1007/s12010-024-04953-z10.1007/s12010-024-04953-z ↗
42. 10.52586/498910.52586/4989 ↗
43. 10.2353/ajpath.2010.09073410.2353/ajpath.2010.090734 ↗
44. 10.1186/s12951-021-00991-510.1186/s12951-021-00991-5 ↗
45. 10.1186/s13045-021-01208-w10.1186/s13045-021-01208-w ↗
46. 10.1038/s41392-022-00971-710.1038/s41392-022-00971-7 ↗
47. 10.1080/15548627.2021.187222710.1080/15548627.2021.1872227 ↗
48. 10.1007/s10557-022-07339-710.1007/s10557-022-07339-7 ↗
49. 10.1186/s13287-020-01761-010.1186/s13287-020-01761-0 ↗
50. 10.1016/j.stem.2022.10.00210.1016/j.stem.2022.10.002 ↗
51. 10.1038/s41586-021-03795-710.1038/s41586-021-03795-7 ↗
52. 10.1038/s41598-022-23650-710.1038/s41598-022-23650-7 ↗
53. 10.1016/j.freeradbiomed.2023.08.02510.1016/j.freeradbiomed.2023.08.025 ↗
54. 10.1016/j.ymthe.2023.07.02610.1016/j.ymthe.2023.07.026 ↗
55. 10.3390/ijms23231518210.3390/ijms232315182 ↗
56. Yuxin J. · Adv. Sci. · 2024 · 11
57. 10.1038/s41421-021-00366-y10.1038/s41421-021-00366-y ↗
58. 10.3389/fimmu.2024.146028610.3389/fimmu.2024.1460286 ↗
59. 10.1038/s41418-023-01230-010.1038/s41418-023-01230-0 ↗
60. 10.1007/s10753-018-0801-z10.1007/s10753-018-0801-z ↗
61. 10.1155/2022/374267810.1155/2022/3742678 ↗
62. 10.3389/fimmu.2021.79504810.3389/fimmu.2021.795048 ↗
63. 10.3389/fimmu.2022.109557710.3389/fimmu.2022.1095577 ↗
64. Dutta B. · CELLS‐BASEL · 2023 · 12
65. 10.1038/s41418-020-0528-x10.1038/s41418-020-0528-x ↗
66. 10.1186/s12951-023-02185-710.1186/s12951-023-02185-7 ↗
67. 10.1161/ATVBAHA.119.31250910.1161/ATVBAHA.119.312509 ↗
68. 10.1038/nature1434410.1038/nature14344 ↗
69. 10.1038/s41419-021-04116-610.1038/s41419-021-04116-6 ↗
70. 10.1111/jcmm.7012710.1111/jcmm.70127 ↗
71. 10.1002/advs.20220721610.1002/advs.202207216 ↗
72. 10.1021/acsnano.3c0171310.1021/acsnano.3c01713 ↗
73. 10.1016/j.biomaterials.2023.12213210.1016/j.biomaterials.2023.122132 ↗